| # | Drug | Count |
|---|---|---|
| 0 | ATORVASTATIN CALCIUM | 639 |
| 1 | EZETIMIBE | 584 |
| 2 | INCLISIRAN | 529 |
| 3 | ASPIRIN | 526 |
| 4 | ASPIRIN 325 MG | 512 |
| 5 | ASPIRIN 81 MG | 512 |
| 6 | ALIROCUMAB | 364 |
| 7 | LEVOTHYROXINE SODIUM | 268 |
| 8 | SIMVASTATIN | 265 |
| 9 | OMEPRAZOLE MAGNESIUM | 222 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INCLISIRAN | 529 | 0.0626 |
| 1 | LOMITAPIDE MESYLATE | 160 | 0.0423 |
| 2 | ALIROCUMAB | 364 | 0.0141 |
| 3 | LORLATINIB | 104 | 0.0140 |
| 4 | BEMPEDOIC ACID | 35 | 0.0130 |
| 5 | EZETIMIBE | 584 | 0.0076 |
| 6 | PITAVASTATIN CALCIUM | 38 | 0.0037 |
| 7 | NIACIN | 33 | 0.0028 |
| 8 | GEMFIBROZIL | 32 | 0.0028 |
| 9 | ATORVASTATIN CALCIUM | 639 | 0.0026 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 824 |
| 1 | Dietary Cholesterol Absorption Inhibitor [EPC] | 622 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 531 |
| 3 | HMG-CoA Reductase Inhibitor [EPC] | 507 |
| 4 | Corticosteroid [EPC] | 378 |
| 5 | PCSK9 Inhibitor [EPC] | 364 |
| 6 | Benzodiazepine [EPC] | 363 |
| 7 | Vitamin C [EPC] | 320 |
| 8 | beta-Adrenergic Blocker [EPC] | 267 |
| 9 | Loop Diuretic [EPC] | 264 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 48 | 0.0142 |
| 1 | PCSK9 Inhibitor [EPC] | 364 | 0.0141 |
| 2 | Dietary Cholesterol Absorption Inhibitor [EPC] | 622 | 0.0067 |
| 3 | Plasma Volume Expander [EPC] | 8 | 0.0026 |
| 4 | Leptin Analog [EPC] | 3 | 0.0024 |
| 5 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 24 | 0.0023 |
| 6 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 100 | 0.0017 |
| 7 | Neurokinin 3 Receptor Antagonist [EPC] | 4 | 0.0017 |
| 8 | Progestin Antagonist [EPC] | 7 | 0.0015 |
| 9 | Antiseptic [EPC] | 6 | 0.0014 |